Dr. Alexander Sulakvelidze
Executive Vice President, Chief Scientific Officer, Intralytix, Inc.
Dr. Alexander Sulakvelidze, Ph.D. is an Executive Vice President and Chief Scientific Officer of Intralytix. He is an internationally recognized expert in phage technology who was instrumental in securing the first ever FDA-approval for phage based food safety product in the World. Dr. Sulakvelidze has published extensively on the subject of phage therapy and biocontrol, including co-editing a major book about bacteriophages entitled “Bacteriophages: Biology and Applications”. He is the author of several issued and pending patents in the field of phage therapy and biocontrol.